Trials / Unknown
UnknownNCT05831488
Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our study aims to assess the relationship between the Seismofit® derived VO2 peak estimate and CPET-measured VO2 peak in patients who are having CPET as part of their preoperative workup. Our aim is to establish whether Seismofit® can be considered a cheaper, less resource intensive and better tolerated alternative to the CPET, or whether it might be useful as a screening tool to efficiently identify patients with exercise intolerance who may benefit from further characterisation by CPET.
Conditions
- Hepato-Biliary Carcinoma in Situ Nos
- Pancreatic Cancer
- Colorectal Cancer
- Gastric Cancer
- Oesophageal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non Interventional |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-10-01
- Completion
- 2024-03-01
- First posted
- 2023-04-26
- Last updated
- 2023-04-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05831488. Inclusion in this directory is not an endorsement.